Genistin

Genistin (genistein 7-O-β-D-glucoside) is a glycosylated isoflavone with molecular formula C₂₁H₂₀O₁₀ and molecular weight 432.38 g/mol. It is the predominant isoflavone glycoside found in soybeans and soy-based foods. Key characteristics: • Primary bioactive identity: β-glucoside conjugate of the aglycone genistein; classified as a phytoestrogen with selective estrogen receptor modulator (SERM)-like activity, showing preferential binding to ERβ over ERα (approximately 20-fold selectivity). • Concentrations in food sources: Soybeans contain approximately 150–250 mg total isoflavones per 100 g dry weight, of which genistin typically constitutes 40–60% (roughly 60–150 mg/100 g). Soy flour provides ~80–200 mg genistin/100 g; tofu ~15–30 mg/100 g; soy milk ~5–15 mg/100 mL; tempeh ~20–50 mg/100 g (partially converted to genistein via fermentation). • Bioavailability notes: Genistin itself has limited direct absorption; it requires hydrolysis by intestinal β-glucosidases (particularly lactase-phlorizin hydrolase) and gut microbiota enzymes to release the bioactive aglycone genistein, which is the absorbed form. Bioavailability of genistein from genistin is estimated at 15–35%, heavily dependent on individual gut microbiome composition. Peak plasma concentrations of genistein (from genistin ingestion) occur at approximately 4–8 hours post-ingestion. Plasma half-life of the resulting genistein is approximately 7–8 hours. Equol-producing individuals (~30–50% of Western populations, ~50–60% of Asian populations) may derive additional bioactive metabolites. • Macronutrient contribution: Negligible as an isolated compound (no caloric, protein, fat, or fiber contribution at pharmacologically relevant doses of 30–100 mg/day). • Associated micronutrients (when consumed via whole soy): Soy matrix co-delivers calcium (~200–280 mg/100 g soybeans), magnesium (~250–280 mg/100 g), iron (~8–16 mg/100 g), zinc (~4–5 mg/100 g), potassium (~1,700–1,800 mg/100 g), folate (~375 µg/100 g), vitamin K₁ (~47 µg/100 g), and soy protein (~36 g/100 g dry soybeans). • Key bioactive properties at molecular level: Tyrosine kinase inhibitor (IC₅₀ ~20–100 µM for EGFR), topoisomerase II inhibitor, antioxidant activity (ORAC values lower than genistein aglycone due to glucoside moiety), inhibitor of NF-κB signaling pathway, and modulator of PPARγ activity. • Supplement dosing context: Clinical trials typically use 30–54 mg/day of genistein (aglycone equivalent), which corresponds to approximately 50–90 mg genistin. Supplements are available as purified genistin, mixed isoflavone glycosides, or aglycone-enriched formulations; aglycone forms show approximately 2–3× higher bioavailability than glycoside forms. • Solubility and stability: Water solubility ~0.5 mg/mL (higher than aglycone genistein at ~0.014 mg/mL due to glucose moiety); relatively heat-stable up to ~150°C; stable at pH 4–8 but susceptible to hydrolysis under strong acidic or alkaline conditions.